Leadership Team

Leadership Team

  • Mark Engel

    CEO

    Mr. Engel has been founding and building life sciences companies  since 1990, including NPO Pharmaceuticals (successful exit); Excel PharmaStudies (successful exit); Tiger Medical Group (successful exit); and Haoyisheng (IPO ready). Mr. Engel also has a family fund investing in life science  organizations.

  • Bryan Li M.D.

    EVP Medical

    China Medical University graduate, majored in Medicine, certified by American ECFMG, and specialized in Dermatology. Trained and worked at the Dermatology Departments of China Medical University and Guangdong Medical University. Dr. Li was a visiting scholar at the Dermatology Department of Asian University in South Korea and a post-doc research fellow at the Dermatology Department of Boston University, with several publications in peer-reviewed Journals. Mr. Li has nearly 30 years experience in medical and clinical operations at Fortune 500 multinationals.

See www.lysigen.com and www.phagelux.com for leadership teams of each subsidiary.